Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
PFIZER
Mumbai, India · 1,244 employees
₹4,755.10
▲+0.94%Pfizer is trading near its 52-week low with modest upside today, reflecting post-pandemic normalization but maintaining strong fundamentals with solid margins and revenue growth.
Exchange
NSI
Currency
INR
Day range
₹4,712.30 – ₹4,839.50
52-week range
₹4,360.10 – ₹5,873.50
Sector
Healthcare
Industry
Drug Manufacturers - General
AI investment rating
AI analysis75% confidence
Current price appears near the lower end of its 52-week range, suggesting potential upside given the company's strong fundamentals and trading below its 52-week high.
19.0% below the 1-year high · trend down
Hedge-fund memo
Today
Modest positive movement as stock continues to recover from recent lows
This week
Consolidating near support levels after recent volatility
This month
Underperforming broader market as pandemic premium continues to fade
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Neutral
24 headlines · 20 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 1 of 3 recent quarters (EPS actual vs. consensus).
44.69 vs 45.1
-0.91% surprise
40.42 vs 35.7
13.22% surprise
41.32 vs 42.3
-2.32% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| PFIZER | 217.54B | 29.60 | — | 39.85% | 15.70% |
| SANOFI | 77.53B | 25.05 | — | 28.33% | -11.90% |
| GLAXO | 444.93B | 43.00 | 49.11% |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 499sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
COVID-19 revenue normalization
Mitigation: Diversification through new drug approvals and pipeline development
Patent expirations
Mitigation: Continuous innovation and acquisition strategy to replenish pipeline
Business intelligence
Competitive moat
Extensive global distribution network, strong R&D capabilities, and established brand recognition provide significant competitive advantage in the pharmaceutical industry.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
FDA approvals for pipeline candidates
Launch of new innovative drugs
Thesis builder
Bull case
Strong R&D pipeline and potential new drug approvals drive sustained growth
Base case
Steady performance from established product portfolio with moderate growth
Bear case
Revenue normalization post-pandemic and patent cliff pressures weigh on performance
Time horizon
12-24 months
Est. CAGR
8-12%
Entry (qual.)
Near current levels or on any significant pullback below 4500 INR
Exit (qual.)
Above 5500 INR or on fundamental deterioration
Overall conviction 75%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how PFIZER fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain PFIZER for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
Attractive entry point near 52-week low with strong fundamentals supporting long-term growth
finance.yahoo.com·1d ago·earnings speculation
Kalkine Media·1d ago·pipeline test crucial
Newswire Canada·1d ago·vaccine program selected
Romania Insider·1d ago·revenue freeze case
simplywall.st·1d ago·mixed valuation outlook
TradingView·1d ago·brokerage buy recommendation
finance.yahoo.com·1d ago·outperforms market returns
MarketWatch·1d ago·strong trading day
scanx.trade·2d ago·dividend declared
Investing.com India·2d ago·expected earnings beat
finance.yahoo.com·2d ago·market sentiment unclear
Barchart.com·2d ago·dividend under scrutiny
ts2.tech·2d ago·cautial gains forecast
Economies.com·2d ago·solid financial results
Sahi·2d ago·AI technology partnership
Quantum Zeitgeist·2d ago·reported earnings growth
marketscreener.com·2d ago·profit rises 6.63%
Business Standard·2d ago·profit revenue increase
cnbctv18.com·2d ago·profit jumps 7%
NDTV Profit·2d ago·profit up 6.6% YoY
scanx.trade·2d ago·profit rises 7%
Business Standard·2d ago·strong Q1 results
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
| 34.42% |
| 2.10% |
| ABBOTINDIA | 589.56B | 37.95 | 34.46% | 27.02% | 6.50% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹4,712.30
Resistance (day/52w high)
₹4,839.50
Volume
41,591
Trend
down
RSI (14)
63
MACD
bullish
MA cross
death
50-day MA
₹4,568.73
200-day MA
₹4,816.67
vs 200-DMA
-1.3%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.